vs
Side-by-side financial comparison of INDEPENDENCE REALTY TRUST, INC. (IRT) and Bio-Techne (TECH). Click either name above to swap in a different company.
Bio-Techne is the larger business by last-quarter revenue ($295.9M vs $165.3M, roughly 1.8× INDEPENDENCE REALTY TRUST, INC.). On growth, INDEPENDENCE REALTY TRUST, INC. posted the faster year-over-year revenue change (2.5% vs -6.4%). Over the past eight quarters, Bio-Techne's revenue compounded faster (4.2% CAGR vs 2.2%).
Brandywine Realty Trust is a Philadelphia-based real estate investment trust (REIT) that invests in office buildings in Philadelphia, Washington, D.C., and Austin, Texas.
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
IRT vs TECH — Head-to-Head
Income Statement — Q1 FY2026 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $165.3M | $295.9M |
| Net Profit | — | $38.0M |
| Gross Margin | — | 64.6% |
| Operating Margin | — | 18.4% |
| Net Margin | — | 12.8% |
| Revenue YoY | 2.5% | -6.4% |
| Net Profit YoY | — | 68.3% |
| EPS (diluted) | $0.00 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $165.3M | — | ||
| Q4 25 | $167.1M | $295.9M | ||
| Q3 25 | $167.1M | — | ||
| Q2 25 | $162.2M | $317.0M | ||
| Q1 25 | $161.2M | $316.2M | ||
| Q4 24 | $161.0M | $297.0M | ||
| Q3 24 | $160.1M | $289.5M | ||
| Q2 24 | $158.4M | $306.1M |
| Q1 26 | — | — | ||
| Q4 25 | $33.3M | $38.0M | ||
| Q3 25 | $6.9M | — | ||
| Q2 25 | $8.0M | $-17.7M | ||
| Q1 25 | $8.4M | $22.6M | ||
| Q4 24 | $-1.0M | $34.9M | ||
| Q3 24 | $12.4M | $33.6M | ||
| Q2 24 | $10.4M | $40.6M |
| Q1 26 | — | — | ||
| Q4 25 | — | 64.6% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 62.7% | ||
| Q1 25 | — | 67.9% | ||
| Q4 24 | — | 65.3% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | — | 66.4% |
| Q1 26 | — | — | ||
| Q4 25 | — | 18.4% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -7.5% | ||
| Q1 25 | — | 12.2% | ||
| Q4 24 | — | 16.0% | ||
| Q3 24 | — | 13.8% | ||
| Q2 24 | — | 15.0% |
| Q1 26 | — | — | ||
| Q4 25 | 19.9% | 12.8% | ||
| Q3 25 | 4.1% | — | ||
| Q2 25 | 5.0% | -5.6% | ||
| Q1 25 | 5.2% | 7.1% | ||
| Q4 24 | -0.6% | 11.7% | ||
| Q3 24 | 7.7% | 11.6% | ||
| Q2 24 | 6.5% | 13.3% |
| Q1 26 | $0.00 | — | ||
| Q4 25 | $0.14 | $0.24 | ||
| Q3 25 | $0.03 | — | ||
| Q2 25 | $0.03 | $-0.11 | ||
| Q1 25 | $0.04 | $0.14 | ||
| Q4 24 | $-0.01 | $0.22 | ||
| Q3 24 | $0.05 | $0.21 | ||
| Q2 24 | $0.05 | $0.26 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $23.3M | $172.9M |
| Total DebtLower is stronger | — | $260.0M |
| Stockholders' EquityBook value | $3.4B | $2.0B |
| Total Assets | $6.1B | $2.5B |
| Debt / EquityLower = less leverage | — | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $23.3M | — | ||
| Q4 25 | $23.6M | $172.9M | ||
| Q3 25 | $23.3M | — | ||
| Q2 25 | $19.5M | $162.2M | ||
| Q1 25 | $29.1M | $140.7M | ||
| Q4 24 | $21.2M | $177.5M | ||
| Q3 24 | $17.6M | $187.5M | ||
| Q2 24 | $21.0M | $152.9M |
| Q1 26 | — | — | ||
| Q4 25 | $2.3B | $260.0M | ||
| Q3 25 | $2.3B | — | ||
| Q2 25 | $2.2B | $346.0M | ||
| Q1 25 | $2.3B | $330.0M | ||
| Q4 24 | $2.3B | $300.0M | ||
| Q3 24 | $2.3B | $300.0M | ||
| Q2 24 | $2.3B | $319.0M |
| Q1 26 | $3.4B | — | ||
| Q4 25 | $3.5B | $2.0B | ||
| Q3 25 | $3.5B | — | ||
| Q2 25 | $3.4B | $1.9B | ||
| Q1 25 | $3.5B | $2.0B | ||
| Q4 24 | $3.4B | $2.1B | ||
| Q3 24 | $3.4B | $2.1B | ||
| Q2 24 | $3.4B | $2.1B |
| Q1 26 | $6.1B | — | ||
| Q4 25 | $6.0B | $2.5B | ||
| Q3 25 | $6.1B | — | ||
| Q2 25 | $6.0B | $2.6B | ||
| Q1 25 | $6.0B | $2.6B | ||
| Q4 24 | $6.1B | $2.7B | ||
| Q3 24 | $5.9B | $2.7B | ||
| Q2 24 | $5.9B | $2.7B |
| Q1 26 | — | — | ||
| Q4 25 | 0.66× | 0.13× | ||
| Q3 25 | 0.66× | — | ||
| Q2 25 | 0.66× | 0.18× | ||
| Q1 25 | 0.65× | 0.16× | ||
| Q4 24 | 0.68× | 0.14× | ||
| Q3 24 | 0.68× | 0.14× | ||
| Q2 24 | 0.66× | 0.15× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IRT
| Rental and other property revenue | $165.2M | 100% |
| Other revenue | $109.0K | 0% |
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
